FTC refunds diet pill customers
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission will accept refund requests until Oct. 27 from customers who bought CortiSlim and CortiStress products. CortiSlim advertising made false and unsubstantiated weight loss claims and CortiStress advertising used false and unsubstantiated disease prevention claims, according to FTC (1"The Tan Sheet" Jan. 8, 2007. p. 4). The settlement between FTC and CortiSlim and CortiStress marketers - idenfited by the commission as Stephen F. Cheng and Window Rock Enterprises Inc., and Gregory S. Cynaumon and Infinity Advertising Inc. - included money for consumer refunds with the actual refund depending on the number of customers who apply. The refund is available to those who purchased the products between Aug. 1, 2003, and May 31, 2006...
You may also be interested in...
FTC Supplement Settlements Spotlight Bayer, Mark First Hoodia Action
Bayer "went too far" with weight-loss and -control claims for its One-A-Day WeightSmart product and violated a 1991 sanction the product's previous owner agreed to, the Federal Trade Commission said Jan. 4 when it announced a record $3.2 million fine against the consumer healthcare giant
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.